Japanese women top global life expectancy for 40th straight year
Their average life expectancy was 87.13 years, a slight drop of 0.01 year from 2023. Men's life expectancy remained unchanged at 81.09, but their global ranking slipped to sixth from fifth, the Ministry of Health, Labor and Welfare said.
Japan was followed in the global ranking for women by South Korea at 86.40 and Spain at 86.34. Among men, Sweden ranked first at 82.29, followed by Switzerland at 82.20 and Norway at 81.59, the ministry said.
Life expectancy for both men and women declined in 2021 and 2022, due largely to the impact of the COVID-19 pandemic, but rebounded in 2023.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Asahi Shimbun
an hour ago
- Asahi Shimbun
WWII Japanese troops' PTSD revealed for 1st time at museum
An exhibit showcasing the psychological trauma that Imperial Japanese Army troops suffered during the Pacific War has opened in a museum in Tokyo's Chiyoda Ward. The materials and items are a result of Japan's first national survey into the trauma experienced by Japanese soldiers. The exhibition opened on July 23 at the Shokei-Kan, a historical materials hall for wounded and sick retired soldiers. Although the show is temporary to coincide with the 80th anniversary of the end of the war, it is scheduled to become a permanent exhibit starting in February next year. The existence of soldiers suffering from psychological conditions such as post-traumatic stress disorder (PTSD) was concealed during the war and remained hidden even in the years following the conflict. However, families of former soldiers are increasingly giving testimonies about the effects of war trauma in recent years. This has attracted attention not only to the soldiers' personal suffering but also to the harm inflicted on their families, such as abuse by veterans struggling with unresolved mental scars. In response to the testimonies of the soldiers' families, the government conducted research during the last fiscal year by collecting and analyzing medical records and personal accounts preserved in former military hospitals and other institutions. The exhibition, titled 'soldiers with emotional wounds,' features stories of veterans who directed violence against family members even after the end of the war. Akio Kuroi, representative of an association for families of Japanese soldiers with PTSD, which has long been offering testimonies, visited the exhibit on July 24. He welcomed the new awareness, saying, 'The government has finally taken the first step.' 'There are still many former soldiers who have not been officially recognized as war-injured by the government,' Kuroi said. 'Their families continue suffering even now. A full-scale investigation must be carried out under the government's responsibility to uncover the reality.'
The Mainichi
2 hours ago
- The Mainichi
Study finds 213 deaths in Tokyo apparently caused by improper A/C use
TOKYO -- There were 213 cases of deaths in the Japanese capital's 23 wards that were believed to have been caused by the improper use of air conditioners, according to joint research by the University of Tokyo Graduate School of Medicine and the Tokyo Metropolitan Medical Examiner's Office. Around 80% of these cases involved people living alone or elderly households. Some deaths are reportedly believed to have been caused by the air conditioner being set to "heating" instead of "cooling," or the remote control running out of batteries. The interim report of the collaborative study on heatstroke examined 1,447 cases between January 2013 and September 2023 in which heat or related factors were suspected to have contributed to the cause of death. According to the report, the deaths were concentrated between June and August. There were 30 to 35 such cases in 2016 and 2017, but that number rose to 250 in 2020 and 258 in 2022. A researcher said the figure "reflects the recent rise in temperatures, and the number of deaths has remained high." Air conditioners were turned off in more than 40% of the 1,295 cases that occurred indoors, excluding cases in which people passed away in saunas or during work. Some deaths were also caused by machine failure and malfunctions, including cases where the air conditioners were running but had been set incorrectly, or were clogged with dust which prevented airflow. The report recommends preventive measures such as replacing remote control batteries in advance and cleaning air conditioner filters. It also urges people to visit any elderly family members living alone to ensure their air conditioners are functioning properly.
Yomiuri Shimbun
2 hours ago
- Yomiuri Shimbun
New Pharmaceuticals Overseas: Change Situation in Which Foreign Drugs are Not Available in Japan
If groundbreaking new drugs are available overseas but cannot be used in Japan, it puts many patients at a disadvantage. This situation must be changed immediately. Cases referred to as 'drug loss,' in which pharmaceuticals newly approved in other countries do not become available in Japan, are increasing. For some time now, new drugs developed by overseas pharmaceutical companies have tended to face delays in being introduced to Japan, due to this country's complicated application procedures for approval and additional clinical trials targeting Japanese patients. This problem has been dubbed 'drug lag.' The government's efforts to proceed with measures, such as strengthening the review system, have reduced delays. Instead of drug lag, however, there is now an increase in cases of drug loss. This is because more overseas companies have not even applied for approval of their products in Japan in recent years, making the situation even more serious. Behind this lies a drastic change in development methods for pharmaceuticals. Advances in life sciences have led to the production of complex biopharmaceuticals using genes and cells, shifting the primary developers from major pharmaceutical manufacturers to emerging companies. Many of them are small businesses, so they are not adequately established to expand globally. Furthermore, in Japan, there is a strong tendency to lower the prices of drugs to curb medical expenses. This may lead many overseas drugmakers to make a business decision that there is little advantage to paying the high costs required to enter the Japanese market. Traditionally, drug loss has been conspicuous for rare ailments and pediatric diseases. However, now that the problem will likely expand to more common diseases such as breast cancer and diabetes, it is feared that patients in Japan will be unable to widely benefit from new drugs that are available overseas. To bring drugs developed overseas to Japan, it is necessary to provide more information to drugmakers and lower hurdles to applying for approval in Japan. To support U.S. companies in their applications, the Health, Labor and Welfare Ministry has established an office in the United States to assist them with the review process. It is also essential to establish a system that maintains prices that reflect the value of new pharmaceuticals. In addition to attracting overseas makers, this would also promote technological innovation in the pharmaceutical industry as a whole. However, public health cannot be steadily protected in Japan through an approach that relies on overseas companies. It is necessary to increase the number of new drugs originating in Japan. Japan's research capabilities are not low, but universities and other institutions find it difficult to directly link their research results to businesses, and this environment is hindering the improvement of pharmaceutical development capabilities. In the United States, many universities, startups and investors are concentrated in Boston to work together to produce a steady stream of new drugs. In Japan as well, it is important to create a similar hub, described as an ecosystem, for advanced academic-industrial collaboration. (From The Yomiuri Shimbun, July 28, 2025)
